Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
International Breast Cancer Intervention Study II (DCIS): Tamoxifen vs Anastrozole in Postmenopausal DCIS
2004-003992-35Phase 3Completed
- Sponsor
- Queen Mary University of London
- Start
- Apr 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of anastrozole, tamoxifen in ductal carcinoma in situ (DCIS), sponsored by Queen Mary University of London. Started Apr 2009; status: completed.
02
Drugs
anastrozoletamoxifen
03
Conditions
ductal carcinoma in situ (DCIS)
Beyond the preview
Go deeper on 2004-003992-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003992-35.